ASO Visual Abstract: Real-World Implications of the SOUND Trial
摘要
Nodal disease burden and oncologic outcomes of 312 real-world patients with HR+HER2−breast cancer meeting SOUND eligibility criteria were similar to the SLNB arm of the SOUND trial, supporting careful implementation of omission of SLNB in this population (https://doi.org/https://doi.org/10.1245/s10434-024-16354-x).